iShares Biotechnology ETF
IBB
#292
ETF rank
NZ$14.22 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
NZ$287.37
Share price
-0.51%
Change (1 day)
16.28%
Change (1 year)
iShares Biotechnology ETF (IBB) seeks to track the performance of the NYSE Biotechnology Index, providing exposure to U.S.-listed companies in the biotechnology sector. The fund offers targeted access to biotech stocks, allowing investors to express a view on the industry.

Premium/Discount for iShares Biotechnology ETF (IBB)

Premium/Discount as of January 30, 2026 : 0.01 %

The premium/discount represents the difference between an ETF's market price and its Net Asset Value (NAV). A positive value indicates the ETF trades at a premium (above NAV), while a negative value indicates it trades at a discount (below NAV).
Important: The data presented here is historical data and may be delayed. It does not reflect the current premium/discount status of the ETF shares.

Premium/Discount historical chart